vimarsana.com

Page 14 - ஆஸ்பென் மருந்தகம் ஹோல்டிங்ஸ் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

South Africa Accuses J&J of Unreasonable Vaccine Demands

South Africa Accuses J&J of Unreasonable Vaccine Demands Bloomberg 45 mins ago S thembile Cele and Janice Kew © Photographer: PHILL MAGAKOE/AFP Vials containing doses of the Johnson & Johnson vaccine against the COVID-19 coronavirus as South Africa proceeds with its inoculation campaign at the Klerksdorp Hospital on February 18, 2021. (Bloomberg) South Africa is facing delays to coronavirus-vaccine supplies because of “unreasonable terms” being demanded by manufacturers including Johnson & Johnson in return for delivering millions of much-needed doses, Health Minister Zweli Mkhize said. The government has been notified by J&J that the company won’t sign off on the order agreed last month until it receives greater assurance of support from the state, Mkhize told lawmakers Wednesday, without being more specific.

South Africa Regulator to Discuss J&J Shot After U S Pause

South Africa Regulator to Discuss J&J Shot After U.S. Pause Bloomberg 1 hr ago Antony Sguazzin © Bloomberg A healthcare worker prepares a dose of the Johnson & Johnson Janssen Covid-19 vaccine at the Charleston Arbors housing development in Charleston, West Virginia, U.S., on Thursday, March 18, 2021. President Joe Biden is poised to meet his goal of delivering 100 million Covid-19 vaccine shots in his first 100 days in office as soon as Thursday, reaching the milestone more than a month ahead of time. (Bloomberg) South African health authorities and scientists will meet Wednesday to discuss the U.S. decision to suspend use of Johnson & Johnson’s Covid-19 vaccine after it was linked to rare blood clots.

SA regulator to discuss J&J shot after US pause

MONEYWEB app instead? Will meet Wednesday. 16:44  Image: Stephen Zenner/Bloomberg South African health authorities and scientists will meet Wednesday to discuss the US decision to suspend use of Johnson & Johnson’s Covid-19 vaccine after it was linked to rare blood clots. The Ministerial Advisory Committee on Covid-19 will be part of the meeting and will advise the government, Barry Schoub, the head of the group, said in an interview. The South African Health Regulatory Products Authority and the scientists running a trial of J&J’s vaccine will be part of the meeting, according to Yuven Gounden, a spokesman for the regulator.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.